TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement in respect of the transfer of shares to IEPF04-12-2021
04-12-2021
Torrent Pharma's positive India show infuses confidence
The weak link remains US sales as regulatory issues with the USFDA on its two manufacturing facilities stand30-11-2021
Torrent Pharmaceuticals Ltd - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Investor Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201529-11-2021
Torrent Pharmaceuticals Ltd - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificate17-11-2021
Torrent Pharmaceuticals Ltd - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Investor Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201511-11-2021
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of rescheduling of Investor/Analyst Meet In furtherance to our letter dated 27-Oct-21 on the captioned subject, we would like to inform that the Investors / Analyst Meet has been rescheduled on 17th November, 2021 instead of on 15th November, 2021.11-11-2021
Buy Torrent Pharmaceuticals: target of Rs 3400: Sharekhan
Sharekhan is bullish on Torrent Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 3400 in its research report dated October 26, 2021.27-10-2021
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Investor Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201527-10-2021
Torrent Pharma standalone Q2 net up 15%
The company's standalone revenue from operations increased to 1,799 crore for the quarter27-10-2021
TORRENT PHARMACEUTICALS LTD. - 500420 - Compliance As Per Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly find enclosed the Related Party Transactions on a consolidated basis for the half year ended on 30-Sep-21. Kindly take note of the above.26-10-2021